Albert Labs secures psilocybin licence from Health Canada

Albert Labs has been granted a Health Canada license for its research and production facility in Burnaby, Canada, which gives it permission for the legal possession, production, assembly, sale, and delivery of psilocybin and other psychoactive controlled substances. 

Category Press Release
Published in Proactive Investors
Country Canada

Companies Featured

Albert Labs
Albert Labs is a publicly listed company (CSE) that uses Real-World Evidence (RWE) to accelerate the psychedelic drug development process.